Journal of the International Association of Providers of AIDS Care (JIAPAC), a bimonthly, peer-reviewed journal, presents original research, research reviews, case studies, and clinical perspectives on the treatment of AIDS around the globe. A primary information resource for both developed and developing regions, explores the following topics and more in a variety of care settings: pathology, co-infections, clinical pharmacotherapeutics, diagnostic testing, epidemiology, health services, and cultural and behavioral influences on AIDS and its treatment.
The journal publishes original research and research reviews and includes the following regular sections:
- Pharma Reviews: Descriptions of specific drug actions, indications, contraindications, and so forth
- Diagnostic Test Reviews: Descriptions of new testing procedures for identifying HIV/AIDS
- Country Profiles: Overviews of how individual nations and their governments are addressing the AIDS epidemic
- Program Reviews and Evaluations: Review and analysis of a specific program (at any level) for AIDS health prevention, education, or treatment
In addition, JIAPAC publishes special sponsored supplements, unpublished briefs, and conference proceedings and abstracts.This journal is a member of the Committee on Publication Ethics (COPE)
Journal of the International Association of Providers of AIDS Care (JIAPAC), a bimonthly, peer-reviewed journal, presents research, research reviews, case studies, and clinical perspectives on the treatment of AIDS around the globe. A primary information resource for both developed and developing regions, JIAPAC explores the following topics and more in a variety of care settings: pathology, coinfections, clinical pharmacotherapeutics, diagnostic testing, epidemiology, health services, cultural and behavioral influences on AIDS and its treatment.
|Jose Zuniga||International Association of Providers of AIDS Care, Washington, DC, USA|
|Benjamin Young, MD, PhD||International Association of Providers of AIDS Care, Washington, DC, USA|
|Bonaventura Clotet||University Hospital Germans Trias i Pujol|
|Jennifer Cocohoba, PharmD, MAS||University of California, San Francisco, USA|
|Ernest Ekong, MD, MPH, PhD||Institute of Human Virology, Nigeria|
|Christine Katlama||European AIDS Clinical Society|
|Jeffrey Kwong DNP, MPH, ANP-C||Columbia University, New York, NY|
|Joep Lange||Tropical Medicine & AIDS University of Amsterdam|
|Jean B. Nachega, MD, PhD||John Hopkins University and Stellenbosh University|
|David Perlman, MD||Mount Sinai School of Medicine, New York, USA|
|Praphan Phanuphak||Thai Red Cross Program on AIDS|
|William Powderly||Mater Misericordiae University Hospital Ltd|
|Gita Ramjee, PhD, MSc||African Medical Research Council, South Africa|
|Celso Ramos-Filho||Federal University of Rio de Janeiro, Brazil|
|Mauro Schechter, MD, PhD||Federal University of Rio de Janeiro, Brazil|
|Schlomo Staszewski||Johann Wolfgang Goethe University, Frankfurt, Germany|
|Stefano Vella||Instituto Superiore Di Sanita|
|Douglas Ward, MD||Dupont Circle Physicians Group, Washington, DC|
Manuscripts should be submitted electronically to http://mc.manuscriptcentral.com/jiapac. Authors will be required to set up an online account on the SageTrack system powered by ScholarOne.
Files should be submitted in Microsoft Word and should include the following elements: complete author names, author contact information, including credentials, affiliations, and acknowledgments, abstract (150 words or less), keywords, references, tables, illustrations, and legends.
All manuscripts should be double-spaced, and, if hard copies are sent by mail, three high-quality copies of each manuscript are required. All hard-copy manuscripts should be accompanied by electronic files on CD. For further guidelines on how to prepare a manuscript, see Uniform requirements for manuscripts submitted to biomedical journals http://www.icmje.org/.
The following guidelines are based on the instructions put forth by the International Committee of Medical Journal Editors. All submissions must follow those instructions, which are published according to the Uniform requirements for manuscripts submitted to biomedical journals", N Engl J Med 1997, 336:309-315.
The Journal of the International Association of Providers of AIDS Care (JIAPAC) is a single-blind peer reviewed journal that seeks original research papers, as well as "Letters to the Editor," "Short Communications" and "State-of-the-Art Reviews."
"Letters to the Editor" should be limited to 750 words. JIAPAC is under no obligation to print any letter or to provide an explanation for why any letter is not printed; the editors will consider the content of each letter in determining whether or not it will be peer-reviewed.
"Short Communications" may be submitted to describe original research findings that do not need to be documented in full-length papers. These submissions should not exceed 2,000 words. Their content will determine whether or not they are peer-reviewed.
"State-of-the-Art Reviews" are also welcome for submission, or may be solicited by the editors. Prior to submission of a review, a written request describing the review, the length and the number of references, figures, and tables should be sent to the Managing Editor.
"Case Reports" are also accepted as long as they are new, interesting, or rare cases. Describe the essence of the report and the case or technique. Highlight the educational value of the case or technique. Cases with clinical significance or implications will be given priority.
A manuscript should only be submitted to JIAPAC if it contains material that has not been submitted elsewhere. At the time that a manuscript is submitted, all of the manuscript’s authors are asked to inform JIAPAC if they have affiliations or financial relationships that might be construed as presenting conflicts of interest.
Authors who seek clarification on decisions relating to the acceptance or rejection of their manuscripts should communicate in writing to the Editor of JIAPAC.
JIAPAC operates a conventional single-blind reviewing policy in which the reviewer’s name is always concealed from the submitting author.
FOR JOURNALS USING RECOMMENDED/OPPOSED REVIEWERS
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
(ii) drafted the article or revised it critically for important intellectual content,
(iii) approved the version to be published.
Please refer to the ICMJE Authorship guidelines.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), JIAPAC additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of conflicting interests
It is the policy of JIAPAC to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.
For more information please visit the SAGE Journal Author Gateway.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki http://www.wma.net/en/30publications/10policies/b3/index.html and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
JIAPAC and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
English Language Services
Authors who would like to refine the use of English in their manuscripts might consider using the services of a professional English-language editing company. Visit http://languageservices.sagepub.com/en/ for more information. An author's use of these services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and the particular company, and any costs incurred are the sole responsibility of the author.
The corresponding author will receive written notice that the manuscript has been received. All manuscripts are subject to blind review by three experts in fields related to the topic or methods of the manuscript. The corresponding author will receive written notice regarding the outcome of the review process. Revised and resubmitted manuscripts will be reviewed by the same reviewers that evaluated the original submission. All manuscripts will be edited to conform to the standards and style of JIAPAC.
Each manuscript must have a title page containing the following: each author’s name, clearly listed with credentials and affiliations; full contact information for the lead author; and e-mail addresses and telephone numbers for co-authors.
Every manuscript submitted to JIAPAC (with the exception of "Letters to the Editor," "Short Communications," and "State-of-the-Art Reviews") must include an abstract; unless the content of the manuscript clearly requires a different abstract format, all abstracts should follow the standard format presented in "Uniform requirements for manuscripts submitted to biomedical journals." If a manuscript contains information that cannot be abstracted in that format, the information should be abstracted in the format that the authors deem most appropriate. Abstracts should not exceed 150 words. Each abstract should be accompanied with four or five keywords chosen by the authors to assist in indexing the paper. Authors are advised to use terms from the Index Medicus medical subject headings list when possible.